Navigation Links
Pharmacyclics Reports Third Quarter 2013 Results
Date:11/7/2013

clinical accomplishments are ahead of our internal expectations," said Bob Duggan, CEO and Chairman of the Board."Most recently we achieved an important milestone with ibrutinib's drug application now being submitted to the European authorities. Together with Janssen, our partner, we are working towards a broad clinical advancement of ibrutinib and have now focused in on making the product commercially available in all major markets around the world. Over the next several quarters, we are anticipating additional clinical and regulatory progress. We are on our way to becoming a true ally for patients and physicians, addressing serious, unmet medical health care needs for patients."

Regulatory and Clinical UpdateTo date, over 2300 patients have been treated in company sponsored trials, over 800 principal investigators have been involved in the conduct of our clinical trials in 37 countries around the globe. Clinical trials are active in all regions including US, Europe, Asia Pacific, Asia, and Latin America. Currently there are eight Phase III clinical trials conducted with ibrutinib and a total of 35 trials are currently registered on www.clinicaltrials.gov.

On October 30, Janssen announced it submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for the use of ibrutinib in the treatment of adult patients with R/R CLL/SLL or R/R MCL, two forms of blood cancer. The EMA filings follow the New Drug Application submission of ibrutinib to the U.S. Food and Drug Administration which was accepted by the agency on August 27, 2013, for its use in the treatment of patients with R/R CLL/SLL or R/R MCL.

Oral Presentations at ASH (December 7-10) for ibrutinibTen Oral Presentations and eleven Poster Presentations for ibrutinib have been accepted at the American Society of Hematology (ASH) Annual Meeting in New Orleans, LA (December 7-10, 2013). These abstracts w
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
2. Pharmacyclics Reports Second Quarter 2013 Results
3. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
4. Pharmacyclics Reports First Quarter 2013 Results
5. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
6. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
7. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
8. Pharmacyclics, Inc. Prices Public Offering of Common Stock
9. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
10. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
11. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015 Patterson Medical, formerly the medical ... ), is now an independent company with today,s ... Medical by Madison Dearborn Partners (MDP).  ... a transition period before rebranding as the world,s ... products.  With the focused resources and expertise of ...
(Date:8/28/2015)... , August 28, 2015 The scientific ... collaboration with one of the leading academics in the field ... world record holder in life extension for model animals - ... biology of aging and age-related diseases, primarily, around the stability ... has just been published as "Stability analysis of a model ...
(Date:8/28/2015)... and PITTSBURGH , Aug. 28, ... today announced that its shareholders have approved Mylan,s ... PRGO ; TASE) and the related issuance of ... extraordinary general meeting of shareholders held today. The ... at the extraordinary general meeting. In addition, the ...
Breaking Medicine Technology:Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
(Date:8/30/2015)... Boca Raton, Fl (PRWEB) , ... August 30, 2015 , ... ... proven to have beneficial effects as sleep aids and calming remedies, which help to ... is the result of a great deal of research in the field of regenerative ...
(Date:8/30/2015)... CA (PRWEB) , ... August 30, 2015 , ... ... Focused Ultrasound (HIFU) medical devices for the treatment of prostate cancer, has announced ... introduced this summer at the treatment center in Puerto Vallarta, Mexico. , The ...
(Date:8/29/2015)... ... , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the Director of Policy ... present an educational program titled “Asbestos and Your Health.” , The two and one ... at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., Ambler, PA 19002. ...
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President of ... increase acceptance of the chiropractic field in the military. All too often VA hospitals ... Chiropractic was made available to the VA program over a decade ago, the reality ...
(Date:8/29/2015)... ... August 29, 2015 , ... People who have heart ... emphysema), or asthma, are at higher risk from wildfire smoke especially in Calgary, ... or heart-rhythm problems (arrhythmia or irregular heartbeat) are also sensitive to air pollution. ...
Breaking Medicine News(10 mins):Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:Image Fusion Technology Combines MRI and Ultrasound Images to Treat Prostate Cancer 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2
... 11 , - Health of the Nation has Declined ... Britain is Overwhelmed, Overworked and Overweight, - 1.9 Million ... The nation appears to be stuck in a downward spiral ... and,money by cutting back on exercise and healthy foods in the current ...
... urban areas are more likely to develop late-stage cancer than ... the conclusion of a new study published in the June ... of the American Cancer Society. The study,s results indicate a ... , Diagnosing cancer at an early stage can improve outcomes. ...
... NEWARK, Calif., May 11 InSound Medical, Inc., today ... ("MD&DI") magazine selected the company,s "100% Invisible" Lyric(R) hearing ... twelfth annual Medical Design Excellence Awards (MDEA.)MDEA is the ... uses an impartial panel of jurors to evaluate entries. ...
... are urged to prevent head, neck injuries , , SUNDAY, ... can help prevent head and neck injuries related to ... Each year in the United States, about 1.5 million ... injuries, and nearly 12,000 are treated for neck fractures, ...
... strain on the system will increase misdiagnosis or late diagnosis of cancers ... Douglas LLP , ... New York, NY (PRWEB) May 10, 2009 -- ... not only cause delays in breast, colon and cervical cancer screening for ...
... recovery is fairly quick , , SATURDAY, May 9 (HealthDay ... now stands at 2,254 confirmed cases and 722 probable cases ... Saturday. , "We had expected more cases and we are ... for science and public health program at the Centers for ...
Cached Medicine News:Health News:Stressed and Sedentary Lifestyles Increase as Recession Appears to Take its Toll on Britain's Health 2Health News:Stressed and Sedentary Lifestyles Increase as Recession Appears to Take its Toll on Britain's Health 3Health News:Stressed and Sedentary Lifestyles Increase as Recession Appears to Take its Toll on Britain's Health 4Health News:City-dwellers have higher risk of late-stage cancer than rural residents 2Health News:'100% Invisible' Lyric(R) Hearing Aid Wins Medical Design Excellence Award 2Health News:Ladders, Swings and More Can Cause Peril 2Health News:Budget Cuts for Free Cancer Screening Clinics in New York Could Put Patients' Lives at Risk, Says New York Medical Malpractice Lawyer 2Health News:Budget Cuts for Free Cancer Screening Clinics in New York Could Put Patients' Lives at Risk, Says New York Medical Malpractice Lawyer 3Health News:Budget Cuts for Free Cancer Screening Clinics in New York Could Put Patients' Lives at Risk, Says New York Medical Malpractice Lawyer 4Health News:Confirmed Swine Flu Cases in U.S. Near 2,300 Mark 2Health News:Confirmed Swine Flu Cases in U.S. Near 2,300 Mark 3Health News:Confirmed Swine Flu Cases in U.S. Near 2,300 Mark 4Health News:Confirmed Swine Flu Cases in U.S. Near 2,300 Mark 5Health News:Confirmed Swine Flu Cases in U.S. Near 2,300 Mark 6Health News:Confirmed Swine Flu Cases in U.S. Near 2,300 Mark 7Health News:Confirmed Swine Flu Cases in U.S. Near 2,300 Mark 8Health News:Confirmed Swine Flu Cases in U.S. Near 2,300 Mark 9Health News:Confirmed Swine Flu Cases in U.S. Near 2,300 Mark 10
... this age group?, ,Babies and young children ... an MDI. , ,Dry powder devices require ... efficiency. , ,Traditional nebulizers have high wastage ... used for this age group are inefficient at ...
... Introducing the new PRONEB® ULTRA compressor. This ... time while delivering more medication to the ... LC PLUS® or PARI LC STAR® Reusable ... optimized for inhalation and retention into the ...
... has been developing diverse medical ... years. Our medical-surgical products have ... innovation, quality and customer satisfaction. ... the Labtron® line of diagnostic ...
... Compressor is for active patients who want ... everywhere. The compressor is small and lightweight, ... AC compatibility (100 to 240V), 12 volt ... freedom to take aerosol treatments away from ...
Medicine Products: